Medicaid expansion is linked to “lower cardiovascular mortality” in states that expanded such coverage under the Affordable Care Act, a JAMA Cardiology study shows.
Category: Forbes
Too Many Older Adults Are Falling, Endangering Themselves And Costing Billions
Too many seniors are falling. The medical system is starting to pay attention but it needs to do more.
At Over $2 Million Zolgensma Is The World’s Most Expensive Therapy, Yet Relatively Cost-Effective
Too often the discussion of a drug’s price is fixated on eye-popping numbers and not value. It’s laudable that ICER redirected us to the discussion of value. In some instances, high prices may be justified by value; in others, not.
Oakland Is Second U.S. City To Legalize Magic Mushrooms
The measure largely means that Oakland police will de-prioritize making arrests for possession of the drug.
Oakland Is Second U.S. City To Legalize Magic Mushrooms
The measure largely means that Oakland police will de-prioritize making arrests for possession of the drug.
Will LGBT Retirees End Up Back In The Closet?
Your life experience living as part of the LGBTQ+ community will likely play a role in where you retire, how much money you have to spend in retirement, and even your healthcare needs as you age. Sadly, homophobia might even drive some part of the com…
Can Gene Editing Stop The Bird Flu? Here Is The Latest With Chickens
This study shows how CRISPR gene editing can make chicken cells resistant to the avian influenza virus.
Trump’s Mexico Tariffs To Hit Medical Device Makers Hard
President Trump’s tariffs could hit nearly $9 billion in medical device imports from Mexico that are produced largely by U.S.-based medtech companies.
The Executive Director Of The International Arts & Minds Lab Has Big Feelings About Arts as Medicine
Susan Magsamen believes that the arts are just as vital to our overall health and wellbeing as medicine is—and when they’re combined with interdisciplinary, collaborative approaches to problem solving, they will help save the world.
On The Toxicity Of Humira And Other Rheumatoid Arthritis Drugs
But articles that trumpet 34,000 deaths on important medicines, that denigrate the FDA’s approval process and that suggest these drugs shouldn’t be on the market, don’t really help the discussion.
